Nebido (Testosterone Undecanoate)

Testosterone undecanoate, the active ingredient in Nebido, is an androgenic anabolic steroid presented as an intramuscular injection for intramuscular use. It is prescribed to treat male hypogonadism by restoring physiological testosterone levels in men with deficient hormone production.

GNH USA supplies Nebido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled sourcing, regulatory compliance, and reliable logistics for global distribution. The company adheres to stringent Good Distribution Practice standards and provides comprehensive documentation to support import and clinical use.

Nebido (testosterone undecanoate) acts on the androgen pathway to replace deficient testosterone in men.

Male hypogonadism: restores normal testosterone concentrations and alleviates related symptoms. Testosterone replacement therapy: maintains physiological hormone levels in men with documented deficiency. Secondary hypogonadism: supports endogenous hormone production when pituitary or hypothalamic dysfunction reduces testosterone output.

Nebido may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Acne: increased sebaceous gland activity leading to skin eruptions. - Increased hematocrit: rise in red blood cell concentration.

Serious or Rare Side Effects: - Erythrocytosis: excessive increase in red blood cells that may raise thrombosis risk. - Cardiovascular events: potential for myocardial infarction or stroke. - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention.

When using Nebido, several precautions should be observed to ensure patient safety.

Monitor hematocrit: regular blood count checks to detect erythrocytosis. Assess cardiovascular risk: evaluate history of heart disease before initiating therapy. Screen for prostate disease: perform PSA testing and digital rectal exam. Avoid use in known hypersensitivity: discontinue if allergic reaction occurs. Pregnancy and breastfeeding: not indicated for women; avoid exposure. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nebido can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: may potentiate anticoagulant effect and increase bleeding risk. - Insulin: may alter glucose control, requiring dose adjustments. - CYP3A4 inhibitors: may raise testosterone levels and increase adverse effect potential.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance blood pressure‑lowering effect. - Glucocorticoids: may exacerbate fluid retention. - Estrogen therapy: may counteract androgenic actions.